Arya, Shipra, Zachary O. Binney, Anjali Khakharia, Chandler A. Long, Luke P. Brewster, Peter W. Wilson, William D. Jordan, and Yazan Duwayri. “High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization.” J Vasc Surg 67, no. 1 (January 2018): 217-228.e1. https://doi.org/10.1016/j.jvs.2017.06.101.
Stern, Jordan R., Danielle E. Cafasso, Andrew J. Meltzer, Darren B. Schneider, Sharif H. Ellozy, and Peter H. Connolly. “Prophylactic Inferior Vena Cava Filter Utilization and Risk Factors for Nonretrieval.” Vasc Endovascular Surg 52, no. 1 (January 2018): 34–38. https://doi.org/10.1177/1538574417740507.
Kirkton, Robert D., Heather L. Prichard, Maribel Santiago-Maysonet, Laura E. Niklason, Jeffrey H. Lawson, and Shannon L. M. Dahl. “Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection.” J Surg Res 221 (January 2018): 143–51. https://doi.org/10.1016/j.jss.2017.08.035.
Shackford, Steven R., Casey E. Dunne, Riyad Karmy-Jones, William Long, Desarom Teso, Martin A. Schreiber, Justin Watson, et al. “The evolution of care improves outcome in blunt thoracic aortic injury: A Western Trauma Association multicenter study.” J Trauma Acute Care Surg 83, no. 6 (December 2017): 1006–13. https://doi.org/10.1097/TA.0000000000001555.
Zhang, Lisheng, Jiao-Hui Wu, James C. Otto, Susan B. Gurley, Elizabeth R. Hauser, Sudha K. Shenoy, Karim Nagi, et al. “Interleukin-9 mediates chronic kidney disease-dependent vein graft disease: a role for mast cells.” Cardiovasc Res 113, no. 13 (November 1, 2017): 1551–59. https://doi.org/10.1093/cvr/cvx177.